Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2005
04/06/2005EP1519921A2 Substituted anthranilic amide derivatives and methods of use
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1414817B1 substituted isoindoles and the use thereof
04/06/2005EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
04/06/2005EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity
04/06/2005EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
04/06/2005CN1604894A 经取代的苯基衍生物 Substituted phenyl derivatives
04/06/2005CN1604893A Cyclic amine compounds
04/06/2005CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/06/2005CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/06/2005CN1195745C Antiviral macrocyclic compounds
04/06/2005CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
04/06/2005CN1195737C HIV proteinase inhibitor
04/06/2005CN1195522C Benzodiazepine derivatives
04/05/2005US6875863 Anticancer agents
04/05/2005US6875789 Pyrazole-derived kinase inhibitors and uses thereof
04/05/2005US6875788 Non-insulin dependent diabetes, antidiabetic agents, dietetics, antilipemic agents, anticholesterol agents, cardiovascular disorders
04/05/2005US6875784 Bactericides; grampositive, gramnegative bacteria
04/05/2005US6875779 Cyclooxygenase inhibitor
04/05/2005US6875770 Antiinflamamtory agents; side effect reduction
04/05/2005CA2371012C 4-(1h-pyrrol-1-yl) imidazoles
04/05/2005CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
03/2005
03/31/2005WO2005028452A1 Substituted triazole derivatives as oxytocin antagonists
03/31/2005WO2005028440A1 Novel gamma secretase inhibitors
03/31/2005WO2005028427A1 Aminoalkylamide substituted cyclohexyl derivatives
03/31/2005WO2005027823A2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/31/2005WO2004108133A3 Modulators of vr1 receptor
03/31/2005WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
03/31/2005WO2004084824A3 Biaryl substituted 6-membered heterocyles as sodium channel blockers
03/31/2005WO2004008837A3 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
03/31/2005US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents
03/31/2005US20050070592 Thrombosis; antiischemic agents; chronic obstructive pulmonary disease; antidiabetic agents; antiarthritic agents ; Alzheimer's disease; anticancer agents; strokes; cardiovascular disorders
03/31/2005US20050070591 Indole derivative
03/31/2005US20050070588 Imidazolyl inhibitors of 15-lipoxygenase
03/31/2005US20050070586 Reacting potassium alcoholates with trityl losartan in methanol, refluxing, distilling out the methanol, crystallization, filtration and vacuum drying; angiotensin II receptor antagonists; hypotensive agents
03/31/2005US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
03/31/2005US20050070570 6,8-Dimethoxy isoquinoline derivatives; useful in the treatment or alleviation of disorders and conditions associated with, or dependent on membrane potential or conductance of cells in mammals, including humans, such as asthma, cystic fibrosis, obstructive pulmonary disease, convulsions, vascular spasms
03/31/2005US20050070562 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/31/2005US20050070561 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer
03/31/2005US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
03/31/2005US20050070550 Benzoimidazole compounds
03/31/2005US20050070546 Tyrosine kinase inhibitors
03/31/2005US20050070527 For leukocyte recruitment inhibition, treating or preventing inflammation and H4 receptor-mediated conditions
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/31/2005US20050066451 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
03/31/2005CA2539159A1 Aminoalkylamide substituted cyclohexyl derivatives
03/31/2005CA2538590A1 Novel gamma secretase inhibitors
03/31/2005CA2538381A1 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518858A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
03/30/2005EP1518855A1 Diaminopyrimidinecarboxa mide derivative
03/30/2005EP1517908A2 Novel benzimidazole derivatives
03/30/2005EP1517905A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
03/30/2005EP1517904A2 Mitotic kinesin inhibitors
03/30/2005EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517895A1 8-(biaryl) quinoline pde4 inhibitors
03/30/2005EP1517892A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
03/30/2005EP1517685A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
03/30/2005EP1264826B1 Novel imidazoline compounds
03/30/2005EP1250133B1 Ophthalmic anti-allergy compositions suitable for use with contact lenses
03/30/2005EP1091942B1 Potassium channel blocking agents
03/30/2005EP1075467B1 Pyrazole derivatives as p-38 map kinase inhibitors
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1194966C Methylation of indole compounds from dimethyl carbonate
03/29/2005US6872834 Phenyl-substituted indoles and indazoles
03/29/2005US6872824 Pyrimidine spirobifluorene oligomer for organic light-emitting device
03/29/2005US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
03/29/2005US6872729 Agricultural/ horticultural fungicides containing said derivatives as the active ingredients.
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872717 Pharmacological uses of azetidine derivatives
03/29/2005US6872714 Methods to modulate conditions mediated by the CXCR4 receptor
03/29/2005US6872690 Spraying on plants, environment
03/29/2005CA2102750C Substituted triazolinones
03/29/2005CA2097444C Angiotensin ii antagonist imidazole derivatives, their preparation and their therapeutic use
03/24/2005WO2005026158A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005WO2005026156A1 Quinazoline derivatives
03/24/2005WO2005026155A1 Benzimidazole acetonitriles
03/24/2005WO2005026154A1 Quinolone antibacterial agents
03/24/2005WO2005026153A1 Quinazoline-2, 4-diones as antibacterial agents
03/24/2005WO2005026152A1 Quinazoline derivatives as antitumor agents
03/24/2005WO2005026131A1 Transition state structure and inhibitors of thymidine phosphorylases
03/24/2005WO2005026130A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
03/24/2005WO2005026129A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
03/24/2005WO2005026120A1 Matrix metalloproteinase inhibitors
03/24/2005WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
03/24/2005WO2005026113A1 1, 3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
03/24/2005WO2005026110A1 Optically active 3,3'-dithiobis(2-amino-2­methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methyl­propionic acid derivative
03/24/2005WO2005025681A2 A system for and a method of manufacturing personal golf putters
03/24/2005WO2005011657A3 Piperazine derivatives and their use as therapeutic agents
03/24/2005WO2005007648A3 Biaryl piperazinyl-pyridine analogues
03/24/2005WO2004087050A3 Mitotic kinesin inhibitors
03/24/2005WO2004067510A8 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005WO2004007500A8 Novel diketopyrrolopyrrole pigments
03/24/2005WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation
03/24/2005US20050065210 Anticholesterol agents; antilipemic agents; arteriosclerosis; cardiovascular disorders; parasiticides; antitumor agents; antiproliferative agents; antidiabetic agents
03/24/2005US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands